Find Federal Grants
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) and Clinical Trial Optional
National Institutes of Health · PAR-18-555
Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)
National Institutes of Health · PAS-18-557
National Institutes of Health · PAR-18-556
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional)
National Institutes of Health · PAR-18-554
Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
National Institutes of Health · PAR-18-549
Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
National Institutes of Health · PAR-18-548
Analytical Validation of Candidate Biomarkers for Neurological Disease (U01 Clinical Trial Optional)
National Institutes of Health · PAR-18-550
Limited Competition: Revision Applications for International Centers of Excellence for Malaria Research (U19 Clinical Trial Optional)
National Institutes of Health · RFA-AI-17-044
Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01 Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-19-007
Reinforcing Africa's Public Health System to prevent, detect and respond to public health threats.
Centers for Disease Control - CGH · CDC-RFA-GH18-1849
National Institutes of Health · PAR-18-552
Limited Competition: Clinical Research Sites for MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01-Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-19-008
SAMHSA Treatment Drug Courts
Substance Abuse and Mental Health Services Adminis · TI-18-008
SBIRT-State
Substance Abuse and Mental Health Services Adminis · TI-18-007
Health Resources and Services Administration · HRSA-18-037
Health Resources and Services Administration · HRSA-18-075
NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required
National Institutes of Health · PAR-18-547
Centers for Disease Control and Prevention - ERA · RFA-DD-18-001
Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional)
National Institutes of Health · PAR-18-544
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional
National Institutes of Health · PAR-18-546